COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.

Weckmann M, Bahmer T, Sand JM, Rank Rønnow S, Pech M, Vermeulen C, Faiz A, Leeming DJ, Karsdal MA, Lunding L, Oliver BGG, Wegmann M, Ulrich-Merzenich G, Juergens UR, Duhn J, Laumonnier Y, Danov O, Sewald K, Zissler U, Jonker M, König I, Hansen G, von Mutius E, Fuchs O, Dittrich AM, Schaub B, Happle C, Rabe KF, van de Berge M, Burgess JK, Kopp MV, ALLIANCE Study Group as part of the German Centre for Lung Research (DZL).

Open source

DOI
10.1183/13993003.03969-2020
Published
2021-12-09
Container
Eur Respir J
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1183/13993003.03969-2020,
  title = {COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.},
  author = {Weckmann M and  Bahmer T and  Sand JM and  Rank Rønnow S and  Pech M and  Vermeulen C and  Faiz A and  Leeming DJ and  Karsdal MA and  Lunding L and  Oliver BGG and  Wegmann M and  Ulrich-Merzenich G and  Juergens UR and  Duhn J and  Laumonnier Y and  Danov O and  Sewald K and  Zissler U and  Jonker M and  König I and  Hansen G and  von Mutius E and  Fuchs O and  Dittrich AM and  Schaub B and  Happle C and  Rabe KF and  van de Berge M and  Burgess JK and  Kopp MV and  ALLIANCE Study Group as part of the German Centre for Lung Research (DZL).},
  year = {2021},
  journal = {Eur Respir J},
  doi = {10.1183/13993003.03969-2020},
  url = {https://doi.org/10.1183/13993003.03969-2020}
}

RIS

TY  - JOUR
TI  - COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.
AU  - Weckmann M
AU  -  Bahmer T
AU  -  Sand JM
AU  -  Rank Rønnow S
AU  -  Pech M
AU  -  Vermeulen C
AU  -  Faiz A
AU  -  Leeming DJ
AU  -  Karsdal MA
AU  -  Lunding L
AU  -  Oliver BGG
AU  -  Wegmann M
AU  -  Ulrich-Merzenich G
AU  -  Juergens UR
AU  -  Duhn J
AU  -  Laumonnier Y
AU  -  Danov O
AU  -  Sewald K
AU  -  Zissler U
AU  -  Jonker M
AU  -  König I
AU  -  Hansen G
AU  -  von Mutius E
AU  -  Fuchs O
AU  -  Dittrich AM
AU  -  Schaub B
AU  -  Happle C
AU  -  Rabe KF
AU  -  van de Berge M
AU  -  Burgess JK
AU  -  Kopp MV
AU  -  ALLIANCE Study Group as part of the German Centre for Lung Research (DZL).
PY  - 2021
JO  - Eur Respir J
DO  - 10.1183/13993003.03969-2020
UR  - https://doi.org/10.1183/13993003.03969-2020
ER  - 

APA

M, W., T, B., JM, S., S, R. R., M, P., C, V., A, F., DJ, L., MA, K., L, L., BGG, O., M, W., G, U., UR, J., J, D., Y, L., O, D., K, S., U, Z., M, J., I, K., G, H., E, V. M., O, F., AM, D., B, S., C, H., KF, R., M, V. D. B., JK, B., MV, K., & (DZL)., A. S. G. A. P. O. T. G. C. F. L. R. (2021). COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.. Eur Respir J. https://doi.org/10.1183/13993003.03969-2020

Source records